Key result
Epicardial LV lead placement following failed percutaneous CRT resulted in similar 90-day survival compared to successful percutaneous CRT, with functional class improving from 3.0 to 2.3.
Why the study?
Outcomes of surgical LV lead placement in patients with failing percutaneous CRT are not well defined.
Does epicardial LV lead placement provide comparable survival and functional improvement in patients with failed percutaneous CRT compared to successful percutaneous CRT?
Cohort
No
Does epicardial LV lead placement provide comparable survival and functional improvement in patients with failed percutaneous CRT compared to successful percutaneous CRT?
Epicardial LV lead placement after failed percutaneous CRT is associated with perioperative morbidity but yields functional improvements and comparable 90-day survival to successful percutaneous CRT.
Answers are grounded in this paper and cite their sources.
Surgical LV lead placement offers a feasible rescue option after failed percutaneous CRT; leaves open need for prospective outcome comparisons.
Outcomes of surgical left ventricular (LV) lead placement in patients with failing percutaneous cardiac resynchronization therapy (CRT) are not well defined. The authors reviewed all primary epicardial LV lead placements at their institution to identify patient population, perioperative course, and structural and functional outcomes, and compared this group with patients who had successful percutaneous CRT. Fourteen patients (11%) required epicardial LV lead placement via left thoracotomy or thoracoscopy with mean intensive care unit stay of 2.1 days and inotrope use in 38%. Complications included ventricular fibrillatory arrest, stroke, hypotension, and major bleeding, but there was no difference in 90-day survival between epicardial and percutaneous CRT lead placement. In survivors, New York Heart Association class improved from 3.0 to 2.3 (P=.008) without a change in ejection fraction or severity of mitral regurgitation. Thus, in patients with unsuccessful percutaneous CRT, epicardial LV lead placement is associated with perioperative morbidity, but with subsequent improvement in functional status without excess mortality.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2006) conducted a cohort in Failing percutaneous cardiac resynchronization therapy (CRT). Epicardial LV lead placement vs. Successful percutaneous CRT was evaluated on 90-day survival. Epicardial LV lead placement following failed percutaneous CRT resulted in similar 90-day survival compared to successful percutaneous CRT, with functional class improving from 3.0 to 2.3.
Synapse has enriched 10 related papers. Consider them for comparative context: